I was responding to M's post that the trial has started - I am saying that it is not started and we have not even seen initial proof of protocol.
Everyone knows that co is working on getting things moving and starting the trial - the discussion was when.
So we do not need your assurance. People who have invested here know about it.
(Just read this Q&A from another biotech conf call - how clear the CEO is in precautions taken to start the trial - so saying that trial has already started without any evidence is not correct -
"The latter. We are in the very final preparations for the study, connecting all the dots, making sure everything is in place, everything is in agreement with the agency. We are little bit taking our time to do the best and most thorough job we can envision to get it right, but there’s no meaningful delay or anything. We are looking to commence in Q2. ")
Market Data 
Markets 
AI
